Clinical trial
Effectiveness & Safety of Ovine Enoxaparin Sodium to Originator Enoxaparin in Non-ST-Segment Elevation ACS Patients
NCT06114641 is registered in ClinicalTrials.gov with PT Bio Farma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness & Safety of Ovine Enoxaparin Sodium to Originator Enoxaparin in Non-ST-Segment Elevation ACS Patients
- Lead sponsor
- PT Bio Farma
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 1, 2023
- Completion date
- August 26, 2024
- Enrollment
- 220 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
effect of drug, safety issues